PharmaResources (301230.SZ) has set up a limited partnership company Li Chen Yanhe, focusing on early-stage investment in biopharmaceuticals.

PharmaResources (301230.SZ) announced that, in order to meet the needs of the company's development strategy, it has signed a partnership agreement with Shanghai Liyuan Enterprise Management Partnership Enterprise (limited partnership) and Shanghai Lichen Yuanding Private Equity Investment Fund Partnership Enterprise (limited partnership) to jointly establish Shanghai Liyuan Yanhe Enterprise Management Partnership Enterprise (limited partnership) (referred to as "Lichen Yanhe"). The company has used its own funds to contribute 7.3 million yuan, accounting for 28.08% of the total investment ratio. Recently, Lichen Yanhe has completed the business registration change. This external investment will focus on early-stage investments in the biopharmaceutical industry, with a strong emphasis on investments in the medical health sector. This aligns with the company's development strategy and will help strengthen the company's investment capabilities, enhance its overall competitiveness, and improve its profitability while ensuring the steady development of the company's main business.